Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Neerja Kaushik-Basu"'
Autor:
Amartya Basu, Tanaji T. Talele, Neerja Kaushik-Basu, Azize Şener, Özlem Bingöl Özakpınar, Derya Özsavcı, Özge Çevik, Göknur Aktay, Şule Gürsoy, Sevil Aydın, İnci Coşkun, Ş. Güniz Küçükgüzel
Publikováno v:
Molecules, Vol 18, Iss 3, Pp 3595-3614 (2013)
A series of novel N-(3-substituted aryl/alkyl-4-oxo-1,3-thiazolidin-2-ylidene)-4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamides 2a–e were synthesized by the addition of ethyl a-bromoacetate and anhydrous sodium acetate
Externí odkaz:
https://doaj.org/article/3975ad1428e64783b3b7460c52fc6a4a
Autor:
Erica Silberstein, Kathleen Mihalik, Laura Ulitzky, Ewan P Plant, Montserrat Puig, Sara Gagneten, Mei-ying W Yu, Neerja Kaushik-Basu, Stephen M Feinstone, Deborah R Taylor
Publikováno v:
PLoS Pathogens, Vol 6, Iss 5, p e1000910 (2010)
HCV (hepatitis C virus) research, including therapeutics and vaccine development, has been hampered by the lack of suitable tissue culture models. Development of cell culture systems for the growth of the most drug-resistant HCV genotype (1b) as well
Externí odkaz:
https://doaj.org/article/d06c43209ebb40debe2634340ae0e236
Autor:
Christophe Pannecouque, Neerja Kaushik-Basu, Esra Tatar, Robert Snoeck, Merve Bilgin, İlkay Küçükgüzel, Gulten Otuk, Graciela Andrei, Erik De Clercq
Novel 2-aryl-5-non-substituted / methyl-1,3-thiazolidine-4-one derivatives 14-33 carrying L-valine core were synthesized by the reaction of acylhydrazones 4-13 with thioglycolic acid / thiolactic acid. Structures of all synthesized compounds 14-33 we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b3c9197f45bcef55e00a3a77301bf90
https://hdl.handle.net/20.500.13055/98
https://hdl.handle.net/20.500.13055/98
Autor:
Neeraj Masand, Satya P. Gupta, Vaishali M. Patil, Subeer Samanta, Maksim Chudayeu, Gurukumar K. R, Neerja Kaushik-Basu
Publikováno v:
Anti-Infective Agents. 15:52-56
Autor:
Geoffrey J. Clark, Daniel Brian Nichols, Diego F. Calvisi, Neerja Kaushik-Basu, Howard Donninger, M. Lee Schmidt, Amartya Basu, Payal Arora
Publikováno v:
Hepatology. 65:1462-1477
Hepatitis C virus (HCV) infection is a common risk factor for the development of liver cancer. The molecular mechanisms underlying this effect are only partially understood. Here, we show that the HCV protein, nonstructural protein (NS) 5B, directly
Autor:
Pelin, Çıkla, Payal, Arora, Amartya, Basu, Tanaji T, Talele, Neerja, Kaushik-Basu, Ş Güniz, Küçükgüzel
Publikováno v:
Marmara pharmaceutical journal. 17
A novel series of new etodolac hydrazide derivatives, 1-[2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-yl)acetyl]-4-alkyl/aryl thiosemicarbazides [3a-h] have been synthesized in this study. The structures of the new compounds were determined
Autor:
Paulo R. R. Costa, Talita de A. Fernandes, Dinesh Manvar, Amartya Basu, Jorge L.O. Domingos, Daniel Brian Nichols, Neerja Kaushik-Basu
Publikováno v:
European Journal of Medicinal Chemistry. 112:33-38
The synthesis of a series of 5-carba-pterocarpens derivatives involving the cyclization of α-aryl-α-tetralones is described. Several compounds demonstrated potent activity and selectivity in vitro against HCV replicon reporter cells. The best profi
Autor:
Neerja Kaushik-Basu, Irem Durmaz, Amartya Basu, Rengul Cetin Atalay, Sevil Şenkardeş, Ş. Güniz Küçükgüzel, Dinesh Manvar
Publikováno v:
European Journal of Medicinal Chemistry
Date of Conference: 18-23 September 2014 Conference Name: 4th International Meeting on Pharmacy and Pharmaceutical and Sciences, 2014 Hepatitis C virus (HCV) infection is a main cause of chronic liver disease, leading to liver cirrhosis and hepatocel
Autor:
Dinesh Manvar, Talita de A. Fernandes, Paulo R. R. Costa, Amartya Basu, Jorge L.O. Domingos, Erdenechimeg Baljinnyam, Eurides F.T. Junior, Neerja Kaushik-Basu
Publikováno v:
European Journal of Medicinal Chemistry. 93:51-54
The synthesis of a novel series of 1-carba-isoflavanones through the α-arylation of α-tetralones is described. Several of these compounds demonstrated potent activity and selectivity in-vitro against HCV replicon reporter cells. Compound 10 (LQB-31
Autor:
İlkay Küçükgüzel, Esra Tatar, Tanaji T. Talele, Javairia Zia, Dinesh Manvar, Bhargav A. Patel, Amartya Basu, Rupa Guhamazumder, Gizem Çakır, Neerja Kaushik-Basu
Publikováno v:
Archiv der Pharmazie. 348:10-22
In continuation of our efforts to develop new derivatives as hepatitis C virus (HCV) NS5B inhibitors, we synthesized novel 5-arylidene-4-thiazolidinones. The novel compounds 29–42, together with their synthetic precursors 22–28, were tested for H